Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets closed

S&P 500
5,998.74
-22.89(-0.38%)
Dow 30
44,722.06
-138.25(-0.31%)
Nasdaq
19,060.48
-115.10(-0.60%)
Russell 2000
2,426.19
+1.88(+0.08%)
Crude Oil
68.79
+0.07(+0.10%)
Gold
2,660.70
-4.10(-0.15%)

Taiko Pharmaceutical Co.,Ltd. (4574.T)

Tokyo - Tokyo Delayed Price. Currency in JPY

Follow

364.00

+2.00

(+0.55%)

As of 09:41AM JST. Market open.

Currency in JPY

Valuation Measures⁴

Market Cap (intraday)	18.17B
Enterprise Value	15.62B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	2.80
Price/Book (mrq)	2.25
Enterprise Value/Revenue	2.41
Enterprise Value/EBITDA	-1.72

Trading Information

Stock Price History

Beta (5Y Monthly)	0.11
52-Week Change ³	19.93%
S&P500 52-Week Change ³	31.33%
52 Week High ³	495.00
52 Week Low ³	263.00
50-Day Moving Average ³	384.42
200-Day Moving Average ³	386.27

Share Statistics

Avg Vol (3 month) ³	114.32k
Avg Vol (10 day) ³	89.25k
Shares Outstanding ⁵	50.19M
Implied Shares Outstanding ⁶	50.61M
Float ⁸	31.37M
% Held by Insiders ¹	42.85%
% Held by Institutions ¹	7.56%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	1.04
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	Dec 29, 2021
Last Split Factor ²	3:1
Last Split Date ³	Mar 30, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Sep 30, 2024

Profitability

Profit Margin	-37.17%
Operating Margin (ttm)	14.19%

Management Effectiveness

Return on Assets (ttm)	0.71%
Return on Equity (ttm)	-26.20%

Income Statement

Revenue (ttm)	6.28B
Revenue Per Share (ttm)	125.40
Quarterly Revenue Growth (yoy)	-10.90%
Gross Profit (ttm)	N/A
EBITDA	844.25M
Net Income Avi to Common (ttm)	-2.34B
Diluted EPS (ttm)	-49.67
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	4.77B
Total Cash Per Share (mrq)	95.11
Total Debt (mrq)	2.23B
Total Debt/Equity (mrq)	27.65%
Current Ratio (mrq)	3.52
Book Value Per Share (mrq)	160.65

Cash Flow Statement

Operating Cash Flow (ttm)	N/A
Levered Free Cash Flow (ttm)	N/A